Your browser doesn't support javascript.
loading
Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis.
Riaz, Hafiza Arooba; Nishwa, Dur E; Fatima, Ameer; Wahid, Braira; Ali, Akhtar; Kumari, Babita; Idrees, Muhammad.
Affiliation
  • Riaz HA; Department of Life Sciences, School of Sciences, University of Management and Technology, Lahore, Pakistan.
  • Nishwa DE; Department of Life Sciences, School of Sciences, University of Management and Technology, Lahore, Pakistan.
  • Fatima A; Hepatobiliary and Gastroenterology Unit, Sheikh Zayed Hospital, Lahore, Pakistan.
  • Wahid B; Department of Life Sciences, School of Sciences, University of Management and Technology, Lahore, Pakistan.
  • Ali A; Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3168, Australia.
  • Kumari B; School of Agriculture and Food, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Idrees M; Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3168, Australia.
Heliyon ; 9(5): e16169, 2023 May.
Article in En | MEDLINE | ID: mdl-37234654
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Heliyon Year: 2023 Type: Article Affiliation country: Pakistan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Heliyon Year: 2023 Type: Article Affiliation country: Pakistan